Osteonecrosis of the Jaws in Patient Received Bisphosphonates and Sunitinib Separately: A Case Report

Recently published reports have suggested that antiangiogenic drugs such as sunitinib could potentiate the osteonecrosis of the jaw (ONJ) induced by bisphosphonates (BPs) and even induce this adverse effect per se. We reported a case of ONJ with renal cell carcinoma under sunitinib medication and hi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashrafi, Farzaneh, Derakhshandeh, Ali, Movahedian, Bijan, Moghaddas, Azadeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632940/
https://www.ncbi.nlm.nih.gov/pubmed/29026845
http://dx.doi.org/10.4103/jrpp.JRPP_17_36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632940/
https://www.ncbi.nlm.nih.gov/pubmed/29026845
http://dx.doi.org/10.4103/jrpp.JRPP_17_36

Ejemplares similares